I welcome the announcement of this much needed safety review. All UK citizens should be confident that the most rigorous safety standards are in place. Can my right hon. Friend confirm that the review will not have an impact on initiatives such as the accelerated access review and the cancer drug fund, which have fast-tracked access to much needed drugs and treatments?
Medicines and Medical Devices Safety Review
Proceeding contribution from
Michelle Donelan
(Conservative)
in the House of Commons on Wednesday, 21 February 2018.
It occurred during Ministerial statement on Medicines and Medical Devices Safety Review.
Type
Proceeding contribution
Reference
636 c181
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2020-07-09 15:43:21 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000040
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000040
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000040